Table 1.
Clinical characteristics and outcome of 94 patients with renal clear cell cancer according to PTENP1 and PTEN gene expression
| PTEN |
PTENP1 |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Biologic characteristics | n | Positive | Rate | x2 | P | Positive | Rate | x2 | P |
| Fuhrman nuclear grading | |||||||||
| I | 28 | 20 | 71.43% | 17.26 | <0.01 | 18 | 64.29% | 11.51 | <0.01 |
| II | 42 | 14 | 33.33% | 15 | 35.71 % | ||||
| III-IV | 24 | 4 | 16.67% | 6 | 25% | ||||
| Clinical stage | |||||||||
| I | 32 | 22 | 68.75% | 10.16 | <0.01 | 21 | 65.63% | 12.27 | <0.01 |
| II | 38 | 13 | 34.21% | 13 | 34.21 % | ||||
| III-IV | 24 | 3 | 12.5% | 5 | 20.83% | ||||
| Lymphatic metastasis | |||||||||
| Yes | 46 | 13 | 28.26% | 5.62 | <0.05 | 12 | 26.09% | 9.12 | <0.01 |
| No | 48 | 25 | 52.08% | 27 | 56.25% | ||||